Skip to content

Changes of Colon Mucosal barrier, alpha-synuclein and Non-coding RNA in patients with PD and their Prediction role on the Progress of PD—a Cohort Study

Changes of Colon Mucosal barrier, alpha-synuclein and Non-coding RNA in patients with PD and their Prediction role on the Progress of PD—a Cohort Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023442
Enrollment
Unknown
Registered
2019-05-27
Start date
2019-07-01
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's diseases

Interventions

Sponsors

Zhujiang Hospital of Southern Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Parkinson's disease (PD) was diagnosed clinically according to the clinical diagnostic criteria of the International Society of Motor Disability (MDS) in 2015. (2) Aged 18 to 80 years; (3) At least one year after the disease was determined; (4) H and Y stages were less than 4 stages; (5) The patient has the ability to answer questionnaires involved in the study.

Exclusion criteria

Exclusion criteria: (1) Parkinson's syndrome caused by toxins, drugs, metabolism and ischemic-brain injury or patients with Parkinson's plus syndrome should be excluded; (2) Those who suffered from severe brain injury or complicated craniotomy in the first half of the year before admission; (3) Those who was not fit to receive colonoscopy for Complicating with serious systemic diseases (cardiopulmonary diseases), consciousness disorders, stroke, severe coronary heart disease, diabetes, liver and kidney diseases; (4) There was a history of intracranial hemorrhage or cerebral infarction within 3 months. (5) Complicated with intestinal or colon diseases. (6) Those who cannot completed reviewers in accordance with the requirements of the research program.

Design outcomes

Primary

MeasureTime frame
Non-coding RNA and mRNA, microRNA;mocosa barrier function test (L/M ratio, DAO, D-lactic acid, PCT, FABP);Mocosa barrier function (CD4,CD8);Mocosa epithelial cells and tight junction (Occludin, Claudin 5, Zo-1);p-alpha-synuclein;UPDRS and nMSS;

Countries

China

Contacts

Public ContactDennis Qing Wang

Zhujiang Hospital of Southern Medical University

wqdennis@126.com+86 13829734526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026